Gotham Asset Management LLC trimmed its position in AmerisourceBergen (NYSE:ABC) by 17.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 285,921 shares of the company’s stock after selling 58,853 shares during the quarter. Gotham Asset Management LLC owned approximately 0.13% of AmerisourceBergen worth $26,253,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. JPMorgan Chase & Co. grew its stake in AmerisourceBergen by 107.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 5,363,429 shares of the company’s stock worth $434,385,000 after buying an additional 2,776,287 shares during the last quarter. Vulcan Value Partners LLC grew its stake in AmerisourceBergen by 29.4% during the 4th quarter. Vulcan Value Partners LLC now owns 7,530,523 shares of the company’s stock worth $691,452,000 after buying an additional 1,710,816 shares during the last quarter. Harding Loevner LP grew its stake in AmerisourceBergen by 89.6% during the 3rd quarter. Harding Loevner LP now owns 3,166,794 shares of the company’s stock worth $134,939,000 after buying an additional 1,496,761 shares during the last quarter. Millennium Management LLC grew its stake in AmerisourceBergen by 429.2% during the 4th quarter. Millennium Management LLC now owns 1,507,690 shares of the company’s stock worth $138,436,000 after buying an additional 1,222,806 shares during the last quarter. Finally, Point72 Asset Management L.P. bought a new position in AmerisourceBergen during the 3rd quarter worth $75,681,000. Institutional investors and hedge funds own 67.30% of the company’s stock.
A number of brokerages recently commented on ABC. Zacks Investment Research downgraded AmerisourceBergen from a “buy” rating to a “hold” rating in a research note on Wednesday, January 31st. Needham & Company LLC lowered their price objective on AmerisourceBergen from $117.00 to $113.00 and set a “buy” rating for the company in a research note on Thursday, February 8th. Goldman Sachs upgraded AmerisourceBergen from a “neutral” rating to a “buy” rating in a research note on Friday, December 15th. Jefferies Group set a $95.00 price objective on AmerisourceBergen and gave the stock a “hold” rating in a research note on Wednesday, February 7th. Finally, Leerink Swann set a $105.00 price objective on AmerisourceBergen and gave the stock a “buy” rating in a research note on Tuesday, January 2nd. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $103.34.
AmerisourceBergen (NYSE:ABC) opened at $93.00 on Tuesday. The firm has a market capitalization of $21,222.22, a P/E ratio of 20.04, a price-to-earnings-growth ratio of 1.44 and a beta of 1.03. The company has a current ratio of 0.95, a quick ratio of 0.50 and a debt-to-equity ratio of 1.61. AmerisourceBergen has a 12-month low of $71.90 and a 12-month high of $106.27.
AmerisourceBergen (NYSE:ABC) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.35 by $0.20. AmerisourceBergen had a return on equity of 53.65% and a net margin of 0.66%. The company had revenue of $40.47 billion during the quarter, compared to analysts’ expectations of $40.42 billion. During the same quarter in the previous year, the company posted $1.36 earnings per share. The business’s revenue was up 6.0% on a year-over-year basis. equities analysts forecast that AmerisourceBergen will post 6.58 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Monday, March 5th. Investors of record on Tuesday, February 20th were paid a $0.38 dividend. This represents a $1.52 annualized dividend and a dividend yield of 1.63%. The ex-dividend date of this dividend was Friday, February 16th. AmerisourceBergen’s dividend payout ratio (DPR) is currently 32.76%.
In other news, insider Peyton R. Howell sold 3,000 shares of the company’s stock in a transaction on Wednesday, March 7th. The shares were sold at an average price of $93.78, for a total transaction of $281,340.00. Following the completion of the transaction, the insider now directly owns 49,189 shares in the company, valued at $4,612,944.42. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Tim G. Guttman sold 11,600 shares of the company’s stock in a transaction on Wednesday, January 3rd. The stock was sold at an average price of $93.40, for a total transaction of $1,083,440.00. The disclosure for this sale can be found here. Insiders have sold 156,809 shares of company stock valued at $14,988,589 over the last 90 days. Corporate insiders own 27.30% of the company’s stock.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.